These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10207351)

  • 1. Adverse drug reaction reporting--1998.
    Sutcliffe H
    CMAJ; 1999 Apr; 160(7):1051, 1055. PubMed ID: 10207351
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reaction reporting--1999.
    Sutcliffe H
    CMAJ; 2000 Apr; 162(7):1044, 1048. PubMed ID: 10763408
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the pharmacogenomics of adverse drug reactions.
    Alvarado I; Wong ML; Licinio J
    Pharmacogenomics J; 2002; 2(5):273. PubMed ID: 12439730
    [No Abstract]   [Full Text] [Related]  

  • 4. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1993.
    Pillans PI; Coulter DM
    N Z Med J; 1994 Nov; 107(990):490-3. PubMed ID: 7970369
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse drug reactions in hospital patients.
    Buechner JS
    Med Health R I; 1998 Feb; 81(2):60-1. PubMed ID: 9505068
    [No Abstract]   [Full Text] [Related]  

  • 6. [The battle against adverse effects of drugs goes on. Comments to a survey].
    Boréus L
    Lakartidningen; 2004 Mar; 101(11):1016-8. PubMed ID: 15055125
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerating statistical research in drug safety.
    Bilker W; Gogolak V; Goldsmith D; Hauben M; Herrera G; Hochberg A; Jolley S; Kulldorff M; Madigan D; Nelson R; Shapiro A; Shmueli G
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):687-8. PubMed ID: 16941519
    [No Abstract]   [Full Text] [Related]  

  • 8. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse.
    Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug warranties and shared responsibility.
    Malik P
    Can J Cardiol; 2005 Apr; 21(5):403. PubMed ID: 15861256
    [No Abstract]   [Full Text] [Related]  

  • 10. Selected control events and reporting odds ratio in signal detection methodology.
    Ooba N; Kubota K
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1159-65. PubMed ID: 20669233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score methods in drug safety studies: practice, strengths and limitations.
    Wang J; Donnan PT
    Pharmacoepidemiol Drug Saf; 2001; 10(4):341-4. PubMed ID: 11760497
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse health effect relief services].
    Sato J; Miyazaki S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():81-6. PubMed ID: 18074521
    [No Abstract]   [Full Text] [Related]  

  • 13. Points to consider: the roles of surveillance and epidemiology in advancing drug safety.
    Edwards R; Faich G; Tilson H;
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):665-7. PubMed ID: 15719353
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward improved adverse event/suspected adverse drug reaction reporting.
    Gross R; Strom BL
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):89-91. PubMed ID: 12642971
    [No Abstract]   [Full Text] [Related]  

  • 16. [A literature review of adverse drug reaction reports. Adverse drug effects can have genetical background].
    Rane A
    Lakartidningen; 2002 May; 99(20):2266-7. PubMed ID: 12082942
    [No Abstract]   [Full Text] [Related]  

  • 17. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An agenda for research on adverse drug reactions.
    Aronson JK
    Br J Clin Pharmacol; 2007 Aug; 64(2):119-21. PubMed ID: 17635504
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reaction reporting--2000: Part 2.
    Sutcliffe H; Macdonald L
    CMAJ; 2001 Jul; 165(1):83, 87. PubMed ID: 11468964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.